http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6160115-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6512
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6512
filingDate 2000-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a138e21023c1238e6669d2465b08250e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06cfa9a9cf85dfb30a8881b6f8ec88d4
publicationDate 2000-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6160115-A
titleOfInvention Process for preparing N-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin -2-yl]-N-methylmethanesulfonamide
abstract N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimid in-2-yl]-N-methylmethanesulfonamide of the formula: is prepared by reaction of [4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyri midin-5-yl]methanol with chlorodiphenylphosphine. Compound I is an intermediate in the synthesis of pharmaceutically active compounds, in particular HMG-Co A. reductase inhibitors.
priorityDate 1999-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0521471-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136230454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226582284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128726141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128120202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223737582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233733971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128726140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224017385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223740564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129679409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128640063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129686317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226596965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223766383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223738729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127854467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224562274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9937035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88263960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57267626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9819937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224668344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5238

Total number of triples: 52.